{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:07:56Z","timestamp":1775664476346,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ajoc.2023.101957","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T14:30:41Z","timestamp":1699626641000},"page":"101957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-785X","authenticated-orcid":false,"given":"Akifumi","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6536-9701","authenticated-orcid":false,"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajoc.2023.101957_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino","year":"1981","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajoc.2023.101957_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.ajoc.2023.101957_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9394(84)90186-7","article-title":"Ocular cicatricial pemphigoid associated with hyperproliferation of the conjunctival epithelium","volume":"98","author":"Thoft","year":"1984","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101957_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0161-6420(95)30980-3","article-title":"Penetrating keratoplasty in cicatrizing conjunctival diseases","volume":"102","author":"Tugal-Tutkun","year":"1995","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajoc.2023.101957_bib5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"9548","key":"10.1016\/j.ajoc.2023.101957_bib6","first-page":"1696","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet","volume":"368","author":"Drucker","year":"2006","journal-title":"Nov 11"},{"issue":"2","key":"10.1016\/j.ajoc.2023.101957_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/jdi.13636","article-title":"Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type 2 diabetes in Japan","volume":"13","author":"Bouchi","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.ajoc.2023.101957_bib8","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3389\/fimmu.2019.01238","article-title":"Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid","volume":"10","author":"Tasanen","year":"2019","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ajoc.2023.101957_bib9","first-page":"808","article-title":"A case of dipeptidyl peptidase-4 inhibitor-related pemphigoid with refractory conjunctival lesion","volume":"126","author":"Karin","year":"2022","journal-title":"Nihon Ganka Gakkai Zasshi"},{"issue":"10","key":"10.1016\/j.ajoc.2023.101957_bib10","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.ajoc.2023.101957_bib11","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.181.2.1120","article-title":"Inhibition of CD26\/dipeptidyl peptidase IV enhances CCL11\/eotaxin-mediated recruitment of eosinophils in vivo","volume":"181","author":"Forssmann","year":"2008","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ajoc.2023.101957_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function","volume":"29","author":"Ohnuma","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ajoc.2023.101957_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2023.04.017","article-title":"Association of genetic variants of HLA-DQA1 with bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors","author":"Ozeki","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101957_bib14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjo.80.4.292","article-title":"Progression of disease in ocular cicatricial pemphigoid","volume":"80","author":"Elder","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2023.101957_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.all.0000244799.33734.d4","article-title":"Ocular cicatricial pemphigoid","volume":"6","author":"Hingorani","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.ajoc.2023.101957_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database","volume":"175","author":"Bene","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ajoc.2023.101957_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12902-021-00689-7","article-title":"The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study","volume":"21","author":"Lambadiari","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"10.1016\/j.ajoc.2023.101957_bib18","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/1346-8138.16061","article-title":"Dipeptidyl peptidase 4 inhibitor-associated mucous membrane pemphigoid","volume":"48","author":"Suezawa","year":"2021","journal-title":"J Dermatol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993623001652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993623001652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:04:25Z","timestamp":1762527865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993623001652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":18,"alternative-id":["S2451993623001652"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101957","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101957"}}